HYPERION DEFI, INC. Investment Income, Interest
HYPERION DEFI, INC. (HYPD) reported Investment Income, Interest of $206.76 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-13
- HYPERION DEFI, INC. investment income, interest for the quarter ending 2026-06-30 was $206.76K, a 842.71% increase year-over-year.
- HYPERION DEFI, INC. investment income, interest for the quarter ending 2026-03-31 was $244.17K, a 590.73% increase year-over-year.
- HYPERION DEFI, INC. investment income, interest for the quarter ending 2025-12-31 was $138.88K, a 498.10% increase year-over-year.
- HYPERION DEFI, INC. investment income, interest for the quarter ending 2025-09-30 was $43.86K, a 2.54% decline year-over-year.
- HYPERION DEFI, INC. investment income, interest for fiscal 2025 was $240.02K, a 5.51% decline from fiscal 2024.
- HYPERION DEFI, INC. investment income, interest for fiscal 2024 was $254.02K, a 63.38% decline from fiscal 2023.
- HYPERION DEFI, INC. investment income, interest for fiscal 2023 was $693.61K.
- HYPERION DEFI, INC. investment income, interest for fiscal 2017 was $2.38K, a 58.98% increase from fiscal 2016.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $206.76K 10-Q · filed 2026-08-13 | $450.93K 10-Q · filed 2026-08-13 | $589.81K derived: sum of 3 quarters · filed 2026-08-13 | $633.67K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $244.17K 10-Q · filed 2026-05-15 | $383.05K derived: sum of 2 quarters · filed 2026-05-15 | $426.90K derived: sum of 3 quarters · filed 2026-05-15 | $448.84K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $138.88K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $182.74K derived: sum of 2 quarters · filed 2026-03-30 | $204.67K derived: sum of 3 quarters · filed 2026-08-13 | $240.02K 10-K · filed 2026-03-30 |
| 2025-09-30 | $43.86K 10-Q · filed 2025-11-14 | $65.79K derived: sum of 2 quarters · filed 2026-08-13 | $101.14K 10-Q · filed 2025-11-14 | $124.36K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $21.93K 10-Q · filed 2026-08-13 | $57.28K 10-Q · filed 2026-08-13 | $80.50K derived: sum of 3 quarters · filed 2026-08-13 | $125.50K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $35.35K 10-Q · filed 2026-05-15 | $58.57K derived: sum of 2 quarters · filed 2026-05-15 | $103.57K derived: sum of 3 quarters · filed 2026-05-15 | $168.43K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $23.22K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $68.22K derived: sum of 2 quarters · filed 2026-03-30 | $133.09K derived: sum of 3 quarters · filed 2026-03-30 | $254.02K 10-K · filed 2026-03-30 |
| 2024-09-30 | $45.00K 10-Q · filed 2025-11-14 | $109.86K derived: sum of 2 quarters · filed 2025-11-14 | $230.80K 10-Q · filed 2025-11-14 | $429.47K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $64.87K 10-Q · filed 2025-08-13 | $185.81K 10-Q · filed 2025-08-13 | $384.47K derived: sum of 3 quarters · filed 2025-08-13 | $593.37K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $120.94K 10-Q · filed 2025-05-19 | $319.61K derived: sum of 2 quarters · filed 2025-05-19 | $528.51K derived: sum of 3 quarters · filed 2025-05-19 | $712.07K derived: sum of 4 quarters · filed 2025-05-19 |
| 2023-12-31 | $198.67K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $407.57K derived: sum of 2 quarters · filed 2025-04-15 | $591.13K derived: sum of 3 quarters · filed 2025-04-15 | $693.61K 10-K · filed 2025-04-15 |
| 2023-09-30 | $208.90K 10-Q · filed 2024-11-12 | $392.46K derived: sum of 2 quarters · filed 2024-11-12 | $494.94K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $183.56K 10-Q · filed 2024-08-14 | $286.04K 10-Q · filed 2024-08-14 | ||
| 2018-06-30 | $1.91K 10-Q · filed 2018-08-14 | $4.04K 10-Q · filed 2018-08-14 | ||
| 2018-03-31 | $2.14K 10-Q · filed 2018-05-09 | |||
| 2017-12-31 | $2.38K 10-K · filed 2018-04-02 | |||
| 2017-06-30 | $288.00 10-Q · filed 2018-08-14 | $731.00 10-Q · filed 2018-08-14 | ||
| 2017-03-31 | $443.00 10-Q · filed 2018-05-09 | |||
| 2016-12-31 | $1.50K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |